Plumbing company Repipe has asked the High Court to take up its case centred on the controversial issue of patent eligibility for computer-implemented inventions, seeking to overturn a judgment it argues sets a new and impermissible test.
Apple has fired back in a lawsuit alleging its iPhone and iPad devices equipped with Touch ID and Face ID technology infringe patents held by an Australian non-practicing entity, hitting the company with its own case claiming the patents are invalid.
Burger giant Hungry Jack’s has lost its bid to have McDonald’s hand over test results showing the “pre-cooked” weight of its Big Mac beef patties, with a judge finding they were not relevant to whether the rival’s Big Jack burger had 25 per cent “more Aussie beef”.
The Full Federal Court has shot down plumbing company Repipe’s appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.
Indian generics giant Dr Reddy’s Laboratories must give Bristol-Myers Squib unit Celgene Corporation three months’ notice before deciding to sell generic versions of blockbuster cancer drug Revlimid in Australia.
US pop star Katy Perry has been accused of using her “financial might” to “snuff out” the small business of an Australian fashion designer, as trial kicked off in a long-running intellectual property dispute over the rights to use the Katy Perry trade mark in Australia.
Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.
IP Australia has won its appeal of a judge’s decision to allow four Aristocrat patents for its popular Lightning Link electronic poker machine to proceed to grant, with the Full Court finding the invention merely implemented an abstract idea on a computer and was not patentable.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.